Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
3.410
-0.190 (-5.28%)
Oct 26, 2026, 11:21 AM EDT - Market open
Impact BioMedical Market Cap
Impact BioMedical has a market cap or net worth of $29.13 million as of October 26, 2026. It is the 33,711th most valuable company in the world and the 4,948th biggest in the United States. Its market cap has increased by 306.76% in one year.
Market Cap
29.13M
Enterprise Value
29.12M
1-Year Change
306.76%
Global Rank
Country Rank
#4,948 United States
Category
ChartMarket Cap Chart
Since the IPO on September 16, 2024, Impact BioMedical's market cap has decreased from $34.49M to $29.13M, a decrease of -15.54%. That is a compound annual growth rate of -7.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 29.13M | -44.86% |
| Dec 31, 2025 | 52.83M | 216.74% |
| Dec 31, 2024 | 16.68M | -51.64% |
| Sep 16, 2024 | 34.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IRulya Therapeutics | 33.64M |
| Celularity | 31.73M |
| Evaxion | 31.36M |
| Filana Therapeutics | 30.70M |
| Metagenomi Therapeutics | 30.43M |
| Aardvark Therapeutics | 30.42M |
| TransCode Therapeutics | 29.97M |
| Aligos Therapeutics | 29.85M |